| No. |
Question |
Answer |
| 1. |
Method of randomisation, in order of preference, as follows:
(i) third party randomisation (pharmacy, computer or telephone)
(ii) true randomisation (opaque numbered envelope or register) |
|
| 2. |
Study design
(i) duration of follow‐up
(ii) type of follow‐up
(iii) presence or absence of blinding to allocation |
|
| 3. |
Size of study
(i) number of women recruited
(ii) number of women randomised
(iii) number of women excluded
(iv) number of women withdrawn and lost to follow‐up
(v) number of women analysed |
|
| 4. |
Study setting
(i) single‐centre or multi‐centre
(ii) location
(iii) timing and duration |
|
| 5. |
Analysis
(i) whether 'intention‐to‐treat' analysis was performed by authors |
|
| 6. |
Criteria for adjuvant treatment
(i) lymph node metastasis
(ii) lymphovascular space invasion
(iii) depth invasion more than 10 mm
(iv) parametrial invasion
(v) non‐squamous histology
(vi) positive surgical margins |
|
